|

CIS-DPI Clinical Trials

1 actively recruiting trial

Also known as: Cisplatin-based Dry Powder for Inhalation

Pipeline

Phase 1/2: 1

Top Sponsors

  • Inhatarget Therapeutics1

Indications

  • Stage IV Lung Cancer1
  • NSCLC (Advanced Non-small Cell Lung Cancer)1
  • Lung Cancer1
  • Cancer1

Other1 trial

Cisplatin (CIS) Administered As Dry Powder for Inhalation (DPI) in Patients with Stage IV Non-Small Cell Lung Cancer
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.